MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2021-22)
- Udyam number
- UDYAM-KR-03-0031689
Alx Biotech Private Limited
Alx Biotech Private Limited - pharma in Bengaluru, Karnataka, India. FY 2026 financials & compliance.
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
Last financials
Mar 2020
Balance sheet date
Last AGM
02 Dec 2020
Annual general meeting
Company status
Active
MCA master data
About Alx Biotech Private Limited
Data last updated:
Alx Biotech Private Limited is a private limited company based in Bengaluru, Karnataka, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 19 October 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24303KA2019PTC128930. Its GSTIN is 29AASCA8551B1ZE (Karnataka).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Kode Lalitha Sudha (Managing Director) and Kode Sashi Kiran.
Its last annual general meeting (AGM) was held on 02 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at Sy – No.36/3 Kathriguppa Thippasandra Varthur, Bengaluru, Karnataka, India – 560087.
Alx Biotech Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-03-0031689).
Company details
CIN U24303KA2019PTC128930
Registration Number 128930
Incorporation Date 19 October 2019
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 02 December 2020
Date of Balance Sheet 31 March 2020
MSME Classification Micro
Udyam Registration UDYAM-KR-03-0031689
Recognitions & Rankings of Alx Biotech
Contact details
Alx Biotech Private Limited's registered office is in Bengaluru, Karnataka. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressSy – No.36/3 Kathriguppa Thippasandra Varthur, Bengaluru, Karnataka, India – 560087
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Alx Biotech Private Limited, buy the company report.
Comprehensive company report
Alx Biotech Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Financials of Alx Biotech Private Limited
FY 2020 filings availableFinancial Statement Summary
| Metrics | FY 2019-20 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2019-20 |
|---|---|
| Profitability | |
| EBITDA Margin | |
| Net Profit Margin | |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Alx Biotech Private Limited, buy the company report.
Board of directors of Alx Biotech Private Limited
Alx Biotech has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kode Sashi Kiran | Director | 19 Oct 2019 | 7 Years 0 Months | Current |
| Kode Lalitha Sudha Also directs: Arunachalamm Renewable Energy Private Limited | Managing Director | 19 Oct 2019 | 7 Years 0 Months | Current |
Auditor
Alx Biotech Private Limited is audited by MURALI & VENKAT for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MURALI & VENKAT | FY 2020 | 002162S |
Shareholding
The shareholding of Alx Biotech Private Limited is on record for FY 2020, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2020 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Alx Biotech Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Alx Biotech Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Alx Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Alx Biotech has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AASCA8551B1ZE | Karnataka | Active | 22 May 2020 |
To see the full GST registrations and return filing status of Alx Biotech Private Limited, buy the company report.
Recent activity
Alx Biotech Private Limited has 3 board changes on record since 2019: 2 appointments and 1 cessation. The latest: Kode Lalitha Sudha ceased to be Director on 10 Feb 2020.
AGM
Alx Biotech Private Limited last Annual general meeting of members was held on 02 Dec 2020 as per latest MCA records.
Filing
Alx Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Bangalore.
Ceased
Kode Lalitha Sudha ceased to be Director.
Appointed
Kode Lalitha Sudha was appointed as Managing Director.
Appointed
Kode Sashi Kiran was appointed as Director.
Incorporation
19 Oct 2019
Alx Biotech Private Limited was registered on 19 Oct 2019 with Roc Bangalore & aged 7 years 10 days as per MCA records.
Frequently asked questions
Alx Biotech is an active private limited company based in Bengaluru, Karnataka, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 19 October 2019 (7+ years old) and is registered under CIN U24303KA2019PTC128930.
Alx Biotech has 2 current directors:
- Kode Lalitha Sudha - Managing Director
- Kode Sashi Kiran - Director
The latest financial statements of Alx Biotech on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 02 December 2020. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Alx Biotech is 29AASCA8551B1ZE, registered in Karnataka.
The CIN (Corporate Identification Number) of Alx Biotech is U24303KA2019PTC128930. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Alx Biotech was incorporated on 19 October 2019, making it 7+ years old. It is registered with the Registrar of Companies, Bangalore.
Kode Lalitha Sudha ceased to be Director on 10 Feb 2020. Kode Lalitha Sudha was appointed as Managing Director on 19 Oct 2019. Kode Sashi Kiran was appointed as Director on 19 Oct 2019.
Yes, Alx Biotech is registered as a micro enterprise under Udyam registration (number: UDYAM-KR-03-0031689).
The registered office of Alx Biotech is at Sy – No.363 Kathriguppa Thippasandra Varthur, Bengaluru, Karnataka, India – 560087.
Alx Biotech operates in the pharma industry, in the drug formulation and development segment.